Amgen India News and Activities

Amgen India is owned by Amgen.

Amgen is one of the...

• Forbes Global 2000 (#202);
• Fortune 500 (#129);
• Global Fortune 500 (#482);
• Nasdaq 100;
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Amgen is a company listed under the stock ticker AMGN (US).

Amgen has a direct presence in 22 countries.

Amgen has 26 subsidiaries including Amgen APAC, Amgen Argentina and Amgen Australia.

They are in:

• Pharmaceuticals78%
• Biotechnology22%

Acquisition, funding and merger involving Amgen.

• Amgen has acquired Dark Blue Therapeutics (posted on January 7 2026).

View the org chart displaying its 9 main executives

Most searched biographies at Amgen India

• Naveen Gullapalli, Managing Director
• Mita Ganatra, Executive Director, Finance
• Dilip Dangi, Quality Compliance Manager

Popular executive movements at Amgen India

• Anjali Rao has joined the company as Executive Director, Human Resources  (posted on June 23 2026).
• Mita Ganatra has joined the company as Executive Director, Finance  (posted on June 1 2026).
• Sachin Maheshwari has joined the company as Head of Talent Lifecycle Delivery Services  (posted on March 30 2026).

Click here to view some more movements at Amgen India

Popular executive movements at Amgen

• Robert Lewis has joined the company as Senior Vice President, Strategy  (posted on June 22 2026).
• Thomas Dittrich has joined the company as Chief Financial Officer  (posted on May 20 2026).
• Peter Griffith, Executive Vice President and Chief Financial Officer, will leave the company on Sep. 1, 2026  (posted on May 20 2026).

Click here to view some more movements at Amgen

Create your alert
to follow the executive moves at Amgen India.

Amgen has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Amgen India

Social media about Amgen India

• Amgen India on Wikipedia, Google News & Yahoo Finance
• Amgen India on LinkedIn, X (Twitter) & YouTube